Innovative research on predicting skin flaps necrosis through quantification of the USP4/TNFAIP2 regulated ‘M1 macrophages-Tregs axis’ via skin barrier monitoring technology

Abstract

Background: Current methods used for assessing random-pattern skin flaps (RPSFs) viability are invasive and subjective. Therefore, this study aimed to establish an accurate and non-invasive method for predicting RPSFs prognosis using skin barrier monitoring technology. Methods: Gene ontology (GO) analysis was employed to identify the potential pathways associated with RPSFs necrosis. Skin barrier monitoring technology, immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) were employed to assess skin barrier integrity, quantify ferroptosis level, and evaluate the recruitment of M1 macrophages and regulatory T cells (Tregs). Clinical samples were also included to validate the accuracy and efficacy of skin barrier monitoring technology in predicting RPSFs necrosis. Results: The necrotic process in RPSFs was characterized by increased infiltration of M1 macrophages and Tregs, accompanied by activated ferroptosis and dysfunction of skin barrier. Notably, Tregs infiltration significantly reduced the necrotic area and restored skin barrier integrity of RPSFs by inhibiting ferroptosis and polarization of M1 macrophages. Mechanistically, USP4 regulated the interaction of M1 macrophages and Tregs (M1 macrophages -Tregs axis) via stabilization of TNFAIP2. Analysis of clinical samples revealed that skin barrier monitoring technology could serve as predictive strategy for RPSFs necrosis. Conclusions: This study demonstrated that the USP4/TNFAIP2 pathway would regulate skin barrier function and ferroptosis via ‘M1 macrophages -Tregs axis’ in RPSFs. And the skin barrier monitoring technology could serve as reliable method for RPSFs necrosis prediction.

Keywords

Skin barrier / Skin flaps / Macrophages / Tregs / Ferroptosis / USP4 / TNFAIP2

References

[1] Kruter L, Rohrer T. Advancement flaps. Dermatologic Surg 2015; 41: S239-46. https://doi.org/10.1097/DSS.0000000000000497.

[2] Nagel SS, Thomas B, Fischer S, Diehm Y, Ziegler B, Bigdeli AK, et al. Random-pattern versus perforator-based adipocutaneous skin paddles for postoperative monitoring of free muscle flaps-a comparative retrospective cohort study. J Plast Reconstr Aesthet Surg 2021; 74: 747-54. https://doi.org/10.1016/j.bjps.2020.10.016.

[3] Schmuth M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, Blunder S, Trafoier T, et al. Skin barrier in atopic dermatitis. J Invest Dermatol 2024; 144: 989-1000.e1. https://doi.org/10.1016/j.jid.2024.03.006.

[4] Nicolaou A, Kendall AC. Bioactive lipids in the skin barrier mediate its functionality in health and disease. Pharmacol Ther 2024; 260: 108681. https://doi.org/10.1016/j.pharmthera.2024.108681.

[5] Alexander H, Brown S, Danby S, Flohr C . Research techniques made simple: transepidermal water loss measurement as a research tool. J Invest Dermatol 2018; 138: 2295-2300.e1. https://doi.org/10.1016/j.jid.2018.09.001.

[6] Sander N, Stölzl D, Fonfara M, Hartmann J, Harder I, Suhrkamp I, et al. Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis. Br J Dermatol 2024; 191: 344-50. https://doi.org/10.1093/bjd/ljae138.

[7] Tan H, Ren H, Chai J, Zhai C, Li T, Zhou X, et al. Protective effect of ginseng berry saponin conversion products on skin photodamage caused by UVB in vitro and in vivo. Food Res Int 2024; 198: 115379. https://doi.org/10.1016/j.foodres.2024.115379.

[8] Wang Y, Wan R, Peng W, Zhao X, Bai W, Hu C. Quercetin alleviates ferroptosis accompanied by reducing M1 macrophage polarization during neutrophilic airway inflammation. Eur J Pharmacol 2023; 938: 175407. https://doi.org/10.1016/j.ejphar.2022.175407.

[9] Yu G, Chen Y, Yang N, Zhang H, Zhang X, Geng Y, et al. Apoptotic bodies derived from fibroblast-like cells in subcutaneous connective tissue inhibit Ferroptosis in ischaemic flaps via the miR-339-5p/KEAP1/Nrf2 axis. Adv Sci (Weinh) 2024; 11: e2307238. https://doi.org/10.1002/advs.202307238.

[10] Hu X, Ren J, Xue Q, Luan R, Ding D, Tan J, et al. Anti-PD-1/PD-L1 and anti-CTLA-4 associated checkpoint inhibitor pneumonitis in non-small cell lung cancer: occurrence, pathogenesis and risk factors (review). Int J Oncol 2023; 63: 122. https://doi.org/10.3892/ijo.2023.5570.

[11] Mathur AN, Zirak B, Boothby IC, Tan M, Cohen JN, Mauro TM, et al. Treg-cell control of a CXCL5-IL-17 inflammatory axis promotes hair-follicle-stem-cell differentiation during skin-barrier repair. Immunity 2019; 50: 655-667.e4. https://doi.org/10.1016/j.immuni.2019.02.013.

[12] Zhang X, Jiang X, Deng H, Yu G, Yang N, Al Mamun A, et al. Engineering exosomes from fibroblast growth factor 1 pre-conditioned adipose-derived stem cells promote ischemic skin flaps survival by activating autophagy. Mater Today Bio 2024; 29: 101314. https://doi.org/10.1016/j.mtbio.2024.101314.

[13] Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q, et al. Spotlight on USP4: structure, function, and regulation. Front Cell Dev Biol 2021; 9: 595159.

[14] Yan L, Shen Y, Song J, Liu L, Ma Z. USP4-mediated deubiquitination of SRC-1 regulates macrophage polarization and asthma inflammation. Exp Lung Res 2025; 51: 50-63. https://doi.org/10.1080/01902148.2025.2506373.

[15] Zhou J, Qiu T, Wang T, Chen Z, Ma X, Zhang L, et al. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. Clin Sci (Lond) 2019; 133: 335-49. https://doi.org/10.1042/CS20180959.

[16] Li M, Sun T, Chang M, Liu T, Feng L, Zhang D, et al. Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia. Front Immunol 2025; 16: 1571332. https://doi.org/10.3389/fimmu.2025.1571332.

[17] Lee J-H, You H-J, Lee T-Y, Kang HJ. Current status of experimental animal skin flap models: ischemic preconditioning and molecular factors. Int J Mol Sci 2022; 23: 5234. https://doi.org/10.3390/ijms23095234.

[18] Fang P, Cheng S, Lai Y, Ma X, Lu K, Lu J, et al. Pharmacodynamic insights into maresin 1: enhancing flap viability via the keap1/Nrf2 axis to control ROS-driven apoptosis and ferroptosis. Eur J Pharm Sci 2024; 203: 106923. https://doi.org/10.1016/j.ejps.2024.106923.

[19] Li J, Lou J, Yu G, Chen Y, Chen R, Chen Z, et al. Targeting TFE3 protects against lysosomal malfunction-induced pyroptosis in random skin flaps via ROS elimination. Front Cell Dev Biol 2021; 9: 643996. https://doi.org/10.3389/fcell.2021.643996.

[20] Liu P, Feng Y, Li H, Chen X, Wang G, Xu S, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett 2020; 25: 10. https://doi.org/10.1186/s11658-020-00205-0.

[21] Werthmöller N, Frey B, Wunderlich R, Fietkau R, Gaipl US. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide-and T-cell-dependent manner. Cell Death Dis 2015; 6:e1761-1. https://doi.org/10.1038/cddis.2015.129.

[22] Dakpa G, Senthil Kumar KJ, Tsao NW, Wang SY. Antcin a, a phytosterol regulates SARS-CoV-2 spike protein-mediated metabolic alteration in THP-1 cells explored by the (1)H-NMR-based metabolomics approach. Phytother Res 2023; 37: 885-902. https://doi.org/10.1002/ptr.7670.

[23] Wang M, Feng Y, Zhang P, Shen K, Su J, Zhong Y, et al. Jiawei maxing Shigan tang alleviates radiation-induced lung injury via TGF-β1/Smad signaling pathway mediated by regulatory T cells. J Ethnopharmacol 2024; 320: 117389. https://doi.org/10.1016/j.jep.2023.117389.

[24] Yang F, Yuan C, Chen F, Qin ZS, Schmitt NC, Lesinski GB, et al. Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer. J Exp Clin Cancer Res 2024; 43: 76. https://doi.org/10.1186/s13046-024-03002-1.

[25] Yang B, Cen Y, Li F, Li Y, Chen B, Zheng J, et al. Discovery of a proteolysis targeting chimera (PROTAC) as a potent regulator of FOXP3. Bioorg Med Chem Lett 2024; 112: 129945. https://doi.org/10.1016/j.bmcl.2024.129945.

[26] Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol 2015; 12: 49-62. https://doi.org/10.1038/nrrheum.2015.169.

[27] Dhar SC, Taylor GI. The delay phenomenon: the story unfolds. Plast Reconstr Surg 1999; 104: 2079-91. https://doi.org/10.1097/00006534-199912000-00021.

[28] Hashimoto I, Abe Y, Ishida S, Kashiwagi K, Mineda K, Yamashita Y, et al. Development of skin flaps for reconstructive surgery: random pattern flap to perforator flap. J Med Investig 2016; 63: 159-62. https://doi.org/10.2152/jmi.63.159.

[29] Inoue Y, Uchiyama A, Amalia SN, Ishikawa M, Kosaka K, Sekiguchi A, et al. Keratinocyte-specific SOX2 overexpression suppressed pressure ulcer formation after cutaneous ischemia-reperfusion injury via enhancement of amphiregulin production. J Invest Dermatol 2024; 144: 142-151.e5. https://doi.org/10.1016/j.jid.2023.06.202.

[30] Zhang J, Zhang D, Yan T, Jiang X, Zhang C, Zhao L, et al. BNIP3 promotes the motility and migration of keratinocyte under hypoxia. Exp Dermatol 2017; 26: 416-22. https://doi.org/10.1111/exd.13248.

[31] Shou Y, Yang L, Yang Y, Xu J. Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis 2021; 12: 1009. https://doi.org/10.1038/s41419-021-04284-5.

[32] Logger JGM, Driessen RJB, de Jong E, van Erp PEJ. Value of GPSkin for the measurement of skin barrier impairment and for monitoring of rosacea treatment in daily practice. Skin Res Technol 2021; 27: 15-23. https://doi.org/10.1111/srt.12900.

[33] Grinich EE, Shah AV, Simpson EL. Validation of a novel smartphone application-enabled, patient-operated skin barrier device. Skin Res Technol 2019; 25: 612-7. https://doi.org/10.1111/srt.12692.

[34] Grinich EE, Topham C, Haynes D, Chung J, Latour E, Simpson EL. Validation of a novel patient-operated device for measuring skin barrier function in atopic dermatitis. Skin Res Technol 2021; 27: 824-30. https://doi.org/10.1111/srt.13027.

[35] Dai X, Mizukami Y, Watanabe K, Tsuda T, Shidahara M, Yoshida S, et al. Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing NRF2 activation in human keratinocytes In vitro. J Invest Dermatol 2025; 145: 1422-1432.e10. https://doi.org/10.1016/j.jid.2024.08.038.

[36] Park N-J, Bong S-K, Lee S, Jung Y, Jegal H, Kim J, et al. Compound K improves skin barrier function by increasing SPINK5 expression. J Ginseng Res 2020; 44: 799-807. https://doi.org/10.1016/j.jgr.2019.11.006.

[37] Gutiérrez-Cerrajero C, Sprecher E, Paller AS, Akiyama M, Mazereeuw-Hautier J, Hernández-Martín A, et al. Ichthyosis. Nat Rev Dis Primers 2023; 9: 2. https://doi.org/10.1038/s41572-022-00412-3.

[38] Kim Y, Lim KM. Skin barrier dysfunction and filaggrin. Arch Pharm Res 2021; 44: 36-48. https://doi.org/10.1007/s12272-021-01305-x.

[39] Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci 2022; 24: 449. https://doi.org/10.3390/ijms24010449.

[40] Vats K, Kruglov O, Mizes A, Samovich SN, Amoscato AA, Tyurin VA, et al. Keratinocyte death by ferroptosis initiates skin inflammation after UVB exposure. Redox Biol 2021; 47: 102143. https://doi.org/10.1016/j.redox.2021.102143.

[41] Chen P, Wang D, Xiao T, Gu W, Yang H, Yang M, et al. ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. Int Immunopharmacol 2023; 122: 110629. https://doi.org/10.1016/j.intimp.2023.110629.

[42] Luan J, Truong C, Vuchkovska A, Guo W, Good J, Liu B, et al. CD80 on skin stem cells promotes local expansion of regulatory T cells upon injury to orchestrate repair within an inflammatory environment. Immunity 2024; 57: 1071-1086.e7. https://doi.org/10.1016/j.immuni.2024.04.003.

[43] Toyama S, Moniaga CS, Nakae S, Kurosawa M, Ogawa H, Tominaga M, et al. Regulatory T cells exhibit Interleukin-33-dependent migratory behavior during skin barrier disruption. Int J Mol Sci 2021; 22: 7443. https://doi.org/10.3390/ijms22147443.

[44] Sullivan JA, Tomita Y, Jankowska-Gan E, Lema DA, Arvedson MP, Nair A, et al. Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance. Cell Rep 2020; 30: 1039-1051.e5. https://doi.org/10.1016/j.celrep.2019.12.081.

[45] Jiang Y, Wang J, Li H, Xia L. IL-35 promotes microglial M2 polarization in a rat model of diabetic neuropathic pain. Arch Biochem Biophys 2020; 685: 108330. https://doi.org/10.1016/j.abb.2020.108330.

[46] Wang R, Liang Q, Zhang Q, Zhao S, Lin Y, Liu B, et al. Ccl2-induced regulatory T cells balance inflammation through macrophage polarization during liver reconstitution. Adv Sci 2024; 11: e2403849. https://doi.org/10.1002/advs.202403849.

[47] Huang Y, Wang Y, Wang X, Lin L, Wang P, Sun J, et al. The effects of the transforming growth factor-beta1 (TGF-beta1) Signaling pathway on cell proliferation and cell migration are mediated by ubiquitin specific protease 4 (USP4) in hypertrophic scar tissue and primary fibroblast cultures. Med Sci Monit 2020; 26: e920736. https://doi.org/10.12659/MSM.920736.

[48] Lin R, Nie J, Ren J, Liang R, Li D, Wang P, et al. USP4 interacts and positively regulates IRF8 function via K48-linked deubiquitination in regulatory T cells. FEBS Lett 2017; 591: 1677-86. https://doi.org/10.1002/1873-3468.12668.

[49] Jin G, Liu Y, Xu W, Li Y, Zhang H, Qiu S, et al. Tnfaip2 promotes atherogenesis by enhancing oxidative stress induced inflammation. Mol Immunol 2022; 151: 41-51. https://doi.org/10.1016/j.molimm.2022.08.019.

[50] Jia L, Shi Y, Wen Y, Li W, Feng J, Chen C. The roles of TNFAIP2 in cancers and infectious diseases. J Cell Mol Med 2018; 22: 5188-95. https://doi.org/10.1111/jcmm.13822.

[51] Xu T, Wang Y, Zhao Z, Wang J, Zhao Z, Yang Y, et al. TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKK β from ubiquitin proteasome degradation. Cell Commun Signal 2025; 23: 83. https://doi.org/10.1186/s12964-025-02077-3.

[52] Barzilai S, Blecher-Gonen R, Barnett-Itzhaki Z, Zauberman A, Lebel-Haziv Y, Amit I, et al. M-sec regulates polarized secretion of inflammatory endothelial chemokines and facilitates CCL2-mediated lymphocyte transendothelial migration. J Leukoc Biol 2016; 99: 1045-55. https://doi.org/10.1189/jlb.3VMA0915-427R.